A new class of epilepsy medications based on an ingredient derived from marijuana could be available as soon as the second half of 2018 in the United States pending Food and Drug Administration approval. Officials from GW Pharmaceuticals, the company that developed the drug, on Wednesday … Read More
The post Marijuana -based anti-seizure drug could hit US market in 2018 after strong study results appeared first on Dagga Magazine.